RESEARCH TRIANGLE PARK – Two Durham-based life science firms – Precision BioSciences and Chimerix – reported losses this week.

The details:

  • Precision 

Precision BioSciences Inc. (DTIL) on Thursday reported a loss of $32.7 million in its second quarter.

The Durhambased company said it had a loss of 63 cents per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

The genome editing company posted revenue of $1.1 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $5.6 million.

Precision BioSciences shares have dropped 52% since the beginning of the year. The stock has decreased 28% in the last 12 months.

  • Chimerix

Chimerix Inc. (CMRX) on Monday reported a loss of $10 million in its second quarter.

The Durham-based company said it had a loss of 16 cents per share.

The biopharmaceutical company posted revenue of $1.4 million in the period.

The company’s shares closed at $3.41. A year ago, they were trading at $2.91.